Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics, Inc. (RAPT) Return on Sales (2020 - 2023)

RAPT Therapeutics' Return on Sales history spans 4 years, with the latest figure at 109.01% for Q1 2023.

  • For Q1 2023, Return on Sales fell 7659.0% year-over-year to 109.01%; the TTM value through Mar 2023 reached 109.01%, down 8712.0%, while the annual FY2022 figure was 56.19%, 3875.0% down from the prior year.
  • Return on Sales for Q1 2023 was 109.01% at RAPT Therapeutics, down from 56.19% in the prior quarter.
  • Across five years, Return on Sales topped out at 8.29% in Q4 2020 and bottomed at 109.01% in Q1 2023.
  • The 4-year median for Return on Sales is 19.31% (2021), against an average of 28.12%.
  • The largest annual shift saw Return on Sales skyrocketed 54bps in 2021 before it plummeted -7659bps in 2023.
  • A 4-year view of Return on Sales shows it stood at 8.29% in 2020, then tumbled by -142bps to 20.09% in 2021, then crashed by -180bps to 56.19% in 2022, then plummeted by -94bps to 109.01% in 2023.
  • Per Business Quant, the three most recent readings for RAPT's Return on Sales are 109.01% (Q1 2023), 56.19% (Q4 2022), and 33.53% (Q3 2022).